1	Bicistronic	_	JJ	_	_	3	NMOD	_	_
2	retroviral	_	JJ	_	_	3	NMOD	_	_
3	vector	_	NN	_	_	4	VMOD	_	_
4	reveals	_	VBZ	_	_	0	ROOT	_	_
5	capacity	_	NN	_	_	4	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	v-erbA	_	NN	_	_	6	PMOD	_	_
8	to	_	TO	_	_	5	NMOD	_	_
9	induce	_	VB	_	_	8	IM	_	_
10	erythroleukemia	_	NN	_	_	9	VMOD	_	_
11	and	_	CC	_	_	8	COORD	_	_
12	to	_	TO	_	_	11	CONJ	_	_
13	co-operate	_	VBP	_	_	12	IM	_	_
14	with	_	IN	_	_	13	VMOD	_	_
15	v-myb	_	NN	_	_	14	PMOD	_	_
16	.	_	.	_	_	4	P	_	_
		
1	Previous	_	JJ	_	_	2	NMOD	_	_
2	studies	_	NNS	_	_	3	VMOD	_	_
3	have	_	VBP	_	_	0	ROOT	_	_
4	shown	_	VBN	_	_	3	VC	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	v-erbA	_	NN	_	_	9	VMOD	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	v-myb	_	NN	_	_	7	CONJ	_	_
9	can	_	MD	_	_	5	SUB	_	_
10	induce	_	VB	_	_	9	VC	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	proliferation	_	NN	_	_	10	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	avian	_	JJ	_	_	16	NMOD	_	_
15	erythroid	_	JJ	_	_	16	NMOD	_	_
16	cells	_	NNS	_	_	13	PMOD	_	_
17	in	_	IN	_	_	12	NMOD	_	_
18	culture	_	NN	_	_	17	PMOD	_	_
19	.	_	.	_	_	3	P	_	_
		
1	To	_	TO	_	_	14	VC	_	_
2	study	_	VB	_	_	1	IM	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	combined	_	JJ	_	_	5	NMOD	_	_
5	effects	_	NNS	_	_	2	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	v-erbA	_	NN	_	_	6	PMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	v-myb	_	NN	_	_	8	CONJ	_	_
10	,	_	,	_	_	14	P	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	two	_	CD	_	_	13	NMOD	_	_
13	oncogenes	_	NNS	_	_	14	VMOD	_	_
14	were	_	VBD	_	_	0	ROOT	_	_
15	engineered	_	VBN	_	_	14	VC	_	_
16	into	_	IN	_	_	15	VMOD	_	_
17	a	_	DT	_	_	20	NMOD	_	_
18	retrovirus	_	NN	_	_	20	NMOD	_	_
19	bicistronic	_	JJ	_	_	20	NMOD	_	_
20	vector	_	NN	_	_	16	PMOD	_	_
21	with	_	IN	_	_	15	VMOD	_	_
22	an	_	DT	_	_	26	NMOD	_	_
23	internal	_	JJ	_	_	26	NMOD	_	_
24	ribosomal	_	JJ	_	_	26	NMOD	_	_
25	entry	_	NN	_	_	26	NMOD	_	_
26	site	_	NN	_	_	21	PMOD	_	_
27	(	_	(	_	_	28	P	_	_
28	IRES	_	NN	_	_	26	PRN	_	_
29	)	_	)	_	_	28	P	_	_
30	or	_	CC	_	_	21	COORD	_	_
31	into	_	IN	_	_	30	CONJ	_	_
32	a	_	DT	_	_	33	NMOD	_	_
33	vector	_	NN	_	_	31	PMOD	_	_
34	with	_	IN	_	_	33	NMOD	_	_
35	a	_	DT	_	_	37	NMOD	_	_
36	splice	_	NN	_	_	37	NMOD	_	_
37	acceptor	_	NN	_	_	34	PMOD	_	_
38	(	_	(	_	_	39	P	_	_
39	SPL	_	NN	_	_	37	PRN	_	_
40	)	_	)	_	_	39	P	_	_
41	.	_	.	_	_	14	P	_	_
		
1	This	_	DT	_	_	2	VMOD	_	_
2	allowed	_	VBD	_	_	0	ROOT	_	_
3	coexpression	_	NN	_	_	2	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	two	_	CD	_	_	7	NMOD	_	_
7	proteins	_	NNS	_	_	4	PMOD	_	_
8	and	_	CC	_	_	3	COORD	_	_
9	a	_	DT	_	_	10	NMOD	_	_
10	comparison	_	NN	_	_	8	CONJ	_	_
11	with	_	IN	_	_	10	NMOD	_	_
12	the	_	DT	_	_	14	NMOD	_	_
13	same	_	JJ	_	_	14	NMOD	_	_
14	vector	_	NN	_	_	11	PMOD	_	_
15	containing	_	VBG	_	_	14	APPO	_	_
16	either	_	CC	_	_	17	DEP	_	_
17	v-erbA	_	NN	_	_	15	VMOD	_	_
18	or	_	CC	_	_	17	COORD	_	_
19	v-myb	_	NN	_	_	18	CONJ	_	_
20	only	_	RB	_	_	2	VMOD	_	_
21	.	_	.	_	_	2	P	_	_
		
1	Both	_	CC	_	_	10	DEP	_	_
2	the	_	DT	_	_	10	NMOD	_	_
3	erbA	_	NN	_	_	4	NMOD	_	_
4	IRES	_	NN	_	_	10	NMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	erbA/myb	_	NN	_	_	8	NMOD	_	_
8	IRES	_	NN	_	_	5	CONJ	_	_
9	virus	_	NN	_	_	10	NMOD	_	_
10	constructs	_	NNS	_	_	11	VMOD	_	_
11	transformed	_	VBD	_	_	0	ROOT	_	_
12	erythroid	_	JJ	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	11	VMOD	_	_
14	after	_	IN	_	_	11	VMOD	_	_
15	infection	_	NN	_	_	14	PMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	bone	_	NN	_	_	18	NMOD	_	_
18	marrow	_	NN	_	_	16	PMOD	_	_
19	or	_	CC	_	_	18	COORD	_	_
20	blastoderm	_	NN	_	_	21	NMOD	_	_
21	cultures	_	NNS	_	_	19	CONJ	_	_
22	.	_	.	_	_	11	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	erbA/myb	_	NN	_	_	4	NMOD	_	_
3	IRES	_	NN	_	_	4	NMOD	_	_
4	virus	_	NN	_	_	5	VMOD	_	_
5	exhibited	_	VBD	_	_	0	ROOT	_	_
6	a	_	DT	_	_	12	NMOD	_	_
7	5-10-fold	_	RB	_	_	8	AMOD	_	_
8	higher	_	JJR	_	_	12	NMOD	_	_
9	transformed	_	JJ	_	_	12	NMOD	_	_
10	colony	_	NN	_	_	12	NMOD	_	_
11	forming	_	VBG	_	_	12	NMOD	_	_
12	efficiency	_	NN	_	_	5	VMOD	_	_
13	than	_	IN	_	_	12	NMOD	_	_
14	the	_	DT	_	_	17	NMOD	_	_
15	erbA	_	NN	_	_	17	NMOD	_	_
16	IRES	_	NN	_	_	17	NMOD	_	_
17	virus	_	NN	_	_	13	PMOD	_	_
18	in	_	IN	_	_	5	VMOD	_	_
19	the	_	DT	_	_	21	NMOD	_	_
20	blastoderm	_	JJ	_	_	21	NMOD	_	_
21	assay	_	NN	_	_	18	PMOD	_	_
22	.	_	.	_	_	5	P	_	_
		
1	Surprisingly	_	RB	_	_	17	VMOD	_	_
2	,	_	,	_	_	17	P	_	_
3	when	_	WRB	_	_	4	VMOD	_	_
4	injected	_	VBN	_	_	17	VMOD	_	_
5	into	_	IN	_	_	4	VMOD	_	_
6	chicken	_	NN	_	_	7	NMOD	_	_
7	embryos	_	NNS	_	_	5	PMOD	_	_
8	in	_	IN	_	_	4	VMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	presence	_	NN	_	_	8	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	helper	_	NN	_	_	13	NMOD	_	_
13	virus	_	NN	_	_	11	PMOD	_	_
14	,	_	,	_	_	17	P	_	_
15	both	_	DT	_	_	16	NMOD	_	_
16	viruses	_	NNS	_	_	17	VMOD	_	_
17	induced	_	VBD	_	_	0	ROOT	_	_
18	an	_	DT	_	_	19	NMOD	_	_
19	erythroleukemia	_	NN	_	_	17	VMOD	_	_
20	in	_	IN	_	_	17	VMOD	_	_
21	about	_	RB	_	_	22	NMOD	_	_
22	half	_	NN	_	_	20	PMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	the	_	DT	_	_	25	NMOD	_	_
25	animals	_	NNS	_	_	23	PMOD	_	_
26	.	_	.	_	_	17	P	_	_
		
1	In	_	IN	_	_	6	VMOD	_	_
2	contrast	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	6	P	_	_
4	no	_	DT	_	_	5	NMOD	_	_
5	leukemia	_	NN	_	_	6	VMOD	_	_
6	was	_	VBD	_	_	0	ROOT	_	_
7	observed	_	VBN	_	_	6	VC	_	_
8	with	_	IN	_	_	7	VMOD	_	_
9	a	_	DT	_	_	12	NMOD	_	_
10	myb	_	NN	_	_	12	NMOD	_	_
11	IRES	_	NN	_	_	12	NMOD	_	_
12	virus	_	NN	_	_	8	PMOD	_	_
13	,	_	,	_	_	8	P	_	_
14	with	_	IN	_	_	8	COORD	_	_
15	spliced	_	VBN	_	_	16	NMOD	_	_
16	vectors	_	NNS	_	_	14	PMOD	_	_
17	containing	_	VBG	_	_	16	APPO	_	_
18	v-erbA	_	NN	_	_	17	VMOD	_	_
19	alone	_	RB	_	_	18	NMOD	_	_
20	or	_	CC	_	_	18	COORD	_	_
21	v-erbA	_	NN	_	_	20	CONJ	_	_
22	in	_	IN	_	_	17	VMOD	_	_
23	combination	_	NN	_	_	22	PMOD	_	_
24	with	_	IN	_	_	23	NMOD	_	_
25	v-myb	_	NN	_	_	24	PMOD	_	_
26	,	_	,	_	_	14	P	_	_
27	nor	_	CC	_	_	14	COORD	_	_
28	with	_	IN	_	_	27	CONJ	_	_
29	erbA	_	NN	_	_	30	NMOD	_	_
30	IRES	_	NN	_	_	34	NMOD	_	_
31	and	_	CC	_	_	30	COORD	_	_
32	erbA/myb	_	NN	_	_	33	NMOD	_	_
33	IRES	_	NN	_	_	31	CONJ	_	_
34	viruses	_	NNS	_	_	28	PMOD	_	_
35	produced	_	VBN	_	_	34	APPO	_	_
36	in	_	IN	_	_	35	VMOD	_	_
37	the	_	DT	_	_	38	NMOD	_	_
38	absence	_	NN	_	_	36	PMOD	_	_
39	of	_	IN	_	_	38	NMOD	_	_
40	helper	_	NN	_	_	41	NMOD	_	_
41	virus	_	NN	_	_	39	PMOD	_	_
42	.	_	.	_	_	6	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	average	_	JJ	_	_	3	NMOD	_	_
3	latency	_	NN	_	_	7	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	leukemia	_	NN	_	_	6	NMOD	_	_
6	induction	_	NN	_	_	4	PMOD	_	_
7	was	_	VBD	_	_	0	ROOT	_	_
8	shorter	_	JJR	_	_	7	VMOD	_	_
9	for	_	IN	_	_	8	AMOD	_	_
10	the	_	DT	_	_	13	NMOD	_	_
11	erbA/myb	_	NN	_	_	13	NMOD	_	_
12	IRES	_	NN	_	_	13	NMOD	_	_
13	virus	_	NN	_	_	9	PMOD	_	_
14	(	_	(	_	_	16	P	_	_
15	3.5	_	CD	_	_	16	NMOD	_	_
16	weeks	_	NNS	_	_	13	PRN	_	_
17	)	_	)	_	_	16	P	_	_
18	than	_	IN	_	_	8	AMOD	_	_
19	for	_	IN	_	_	18	PMOD	_	_
20	the	_	DT	_	_	23	NMOD	_	_
21	erbA	_	NN	_	_	23	NMOD	_	_
22	IRES	_	NN	_	_	23	NMOD	_	_
23	virus	_	NN	_	_	19	PMOD	_	_
24	(	_	(	_	_	26	P	_	_
25	5	_	CD	_	_	26	NMOD	_	_
26	weeks	_	NNS	_	_	23	PRN	_	_
27	)	_	)	_	_	26	P	_	_
28	.	_	.	_	_	7	P	_	_
		
1	Nevertheless	_	RB	_	_	9	VMOD	_	_
2	,	_	,	_	_	9	P	_	_
3	for	_	IN	_	_	9	VMOD	_	_
4	both	_	DT	_	_	5	NMOD	_	_
5	viruses	_	NNS	_	_	3	PMOD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	leukemic	_	JJ	_	_	8	NMOD	_	_
8	blasts	_	NNS	_	_	9	VMOD	_	_
9	retained	_	VBD	_	_	0	ROOT	_	_
10	full	_	JJ	_	_	12	NMOD	_	_
11	factor	_	NN	_	_	12	NMOD	_	_
12	dependence	_	NN	_	_	9	VMOD	_	_
13	for	_	IN	_	_	12	NMOD	_	_
14	growth	_	NN	_	_	13	PMOD	_	_
15	.	_	.	_	_	9	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	show	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	v-erbA	_	NN	_	_	6	VMOD	_	_
6	is	_	VBZ	_	_	4	SUB	_	_
7	capable	_	JJ	_	_	6	VMOD	_	_
8	of	_	IN	_	_	7	AMOD	_	_
9	inducing	_	VBG	_	_	8	PMOD	_	_
10	an	_	DT	_	_	11	NMOD	_	_
11	erythroleukemia	_	NN	_	_	9	VMOD	_	_
12	when	_	WRB	_	_	13	VMOD	_	_
13	expressed	_	VBN	_	_	6	VMOD	_	_
14	by	_	IN	_	_	13	VMOD	_	_
15	a	_	DT	_	_	19	NMOD	_	_
16	high	_	JJ	_	_	19	NMOD	_	_
17	titer	_	NN	_	_	19	NMOD	_	_
18	bicistronic	_	JJ	_	_	19	NMOD	_	_
19	retrovirus	_	NN	_	_	14	PMOD	_	_
20	under	_	IN	_	_	13	VMOD	_	_
21	conditions	_	NNS	_	_	20	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	virus	_	NN	_	_	24	NMOD	_	_
24	spreading	_	NN	_	_	22	PMOD	_	_
25	and	_	CC	_	_	4	COORD	_	_
26	that	_	IN	_	_	25	CONJ	_	_
27	its	_	PRP$	_	_	34	NMOD	_	_
28	in	_	FW	_	_	29	AMOD	_	_
29	vitro	_	FW	_	_	34	NMOD	_	_
30	and	_	CC	_	_	29	COORD	_	_
31	in	_	FW	_	_	32	AMOD	_	_
32	vivo	_	FW	_	_	30	CONJ	_	_
33	transforming	_	NN	_	_	34	NMOD	_	_
34	potential	_	NN	_	_	35	VMOD	_	_
35	can	_	MD	_	_	26	SUB	_	_
36	be	_	VB	_	_	35	VC	_	_
37	enhanced	_	VBN	_	_	36	VC	_	_
38	by	_	IN	_	_	37	VMOD	_	_
39	v-myb	_	NN	_	_	38	PMOD	_	_
40	.	_	.	_	_	3	P	_	_
		
